3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia » Globe Newswire - TCN.VN

Pangea Releases Annual Report + Advanced Products 11-12-2023, 22:00

Boehringer’s new zongertinib data demonstrate durable and clinically meaningful results in patients with HER2 (ERBB2)-mutant advanced NSCLC 28-04-2025, 20:23

Staffbase unveils the first AI-native Employee Experience Platform 17-09-2025, 07:00

23-01-2026, 04:05

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Notified -

Globe Newswire23-01-2026, 04:05

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.